• 3910 Citations
  • 37 h-Index
1991 …2020
If you made any changes in Pure these will be visible here soon.

Personal profile


  • 1993 PhD,Department of Genetics, Michigan State University


  • 1995~1999 Associate Professor, Institute of Toxicology, Chung Shan Medical Univ., Taichung, Taiwan
  • 1999~2006 Professor, Department of Life Science, National Taiwan Normal Univ., Taipei, Taiwan
  • 2006~2015 Distinguished Professor, Department of Pharmacology, National Cheng Kung University, Tainan, Taiwan
  • 2015~now Chair Professor, Department of Pharmacology & Institute of Basic Medical Science & Institute of Clinical Medical Science, National Cheng Kung University, Tainan, Taiwan

Research Interests

  • Molecular cancer biology
  • Cancer epigenetics
  • Transcription deregulation in cancer
  • Vesicle trafficking in tumor microenvironment
  • Anticancer drug development

Fingerprint Dive into the research topics where Yi-Ching Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 72 Similar Profiles
Lung Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Methylation Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Genes Medicine & Life Sciences
Histone Deacetylase Inhibitors Medicine & Life Sciences
Lung Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2006 2020

Research Output 1991 2019

1 Citation (Scopus)

AKT-mediated phosphorylation enhances protein stability and transcription activity of ZNF322A to promote lung cancer progression

Liao, S. Y., Kuo, I. Y., Chen, Y. T., Liao, P. C., Liu, Y. F., Wu, H. Y., Lai, W. W. & Wang, Y. C., 2019 Oct 10, In : Oncogene. 38, 41, p. 6723-6736 14 p.

Research output: Contribution to journalArticle

Protein Stability
Lung Neoplasms
Cyclin D1
Chromatin Immunoprecipitation

High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma

Lin, C. H., Li, H. Y., Liu, Y. P., Kuo, P. F., Wang, W. C., Lin, F. C., Chang, W. L., Sheu, B. S., Wang, Y. C., Hung, W. C., Cheng, H. C., Yao, Y. C., Calkins, M. J., Hsiao, M. & Lu, P. J., 2019 Jan 1, In : Therapeutic Advances in Medical Oncology. 11

Research output: Contribution to journalArticle

Open Access
Stem Cells
Neoplastic Stem Cells
4 Citations (Scopus)

LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P

Tan, B. S., Yang, M. C., Singh, S., Chou, Y. C., Chen, H. Y., Wang, M. Y., Wang, Y. C. & Chen, R. H., 2019 Jul 11, In : Oncogene. 38, 28, p. 5612-5626 15 p.

Research output: Contribution to journalArticle

Lung Neoplasms
Long Noncoding RNA
Breast Neoplasms
Neoplasm Metastasis
Mi-2 Nucleosome Remodeling and Deacetylase Complex
2 Citations (Scopus)
Open Access
Esophageal Neoplasms
DNA Repair
DNA Damage
1 Citation (Scopus)


AKT promotes protein stability and transcriptional activity of ZNF322A oncoprotein in lung cancer

Author: 玉婷, 陳., 2017 Aug 22

Supervisor: Wang, Y. (Supervisor)

Student thesis: Master's Thesis

Characterization of transcriptional mechanism and transcriptional network of oncogenic zinc finger protein ZNF322A

Author: 婕羽, 任., 2015 Oct 27

Supervisor: Wang, Y. (Supervisor)

Student thesis: Doctoral Thesis

Exocytosis of secreted frizzled-related protein 1 by Rab37 in suppression of lung cancer stemness

Author: 書慧, 卓., 2017 Aug 22

Supervisor: Wang, Y. (Supervisor)

Student thesis: Master's Thesis

Overexpression of ZNF322A in lung cancer cells promotes neo-angiogenesis

Author: 莉婷, 吳., 2017 Aug 25

Supervisor: Wang, Y. (Supervisor)

Student thesis: Master's Thesis